Latest Regulatory Approvals News

Nyrada Inc. reports promising preclinical results for its lead drug NYR-BI03, showing an 86% cardioprotective effect, alongside a strong financial position bolstered by a AU$3.29 million capital raise. The company has submitted its Phase Ia clinical trial package, setting the stage for human testing.

Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.

BPH Global has completed its acquisition of Indonesian seaweed assets, establishing a wholly owned subsidiary and launching joint operations aimed at expanding seaweed cultivation and bio-stimulant product development across Asia.

Imricor Medical Systems reports strong Q4 CY24 progress with successful FDA review, CE Mark submissions, and an 840% jump in consumables revenue, positioning the company for expanded global market penetration.

Orpheus Uranium Limited reports a productive December quarter marked by a successful $1.66 million capital raise, completion of a major gravity survey at Mount Douglas, and ongoing progress toward regulatory approvals for advanced uranium exploration.

Chalice Mining reports a robust cash position of approximately $90 million and no debt as it progresses the Gonneville Project towards a targeted Final Investment Decision in 2027. The appointment of Dan Brearley as COO signals strengthened operational leadership amid ongoing metallurgical testwork and exploration activities.

Titanium Sands Limited confirms that retention applications for its lapsed Orion Exploration Licences are approved in principle, with formal renewals pending amid Sri Lankan regulatory delays. The company remains confident in progressing its Mannar Island Project and securing necessary environmental and mining approvals.

NuEnergy has finalized the Gas Sales and Purchase Agreement for its Tanjung Enim project and is advancing drilling preparations, marking a key step toward production and revenue generation.

Latin Resources Limited will be suspended from ASX trading following court approval of its acquisition by Pilbara Minerals Limited, marking a significant consolidation in the Australian minerals sector.

Latin Resources Limited confirms the legal effectiveness of its acquisition by Pilbara Minerals Limited via share and option schemes, setting the stage for key trading milestones.

Diatreme Resources has advanced its Northern Silica Project’s environmental studies to the final stages, completing critical groundwater and ecological assessments ahead of a mid-2025 draft EIS submission.

Patagonia Lithium Ltd has announced a maiden JORC Inferred Mineral Resource Estimate of 3.8 million tonnes of Lithium Carbonate Equivalent at its Formentera Lithium Brine Project in Argentina, highlighting significant potential for resource upgrades through ongoing drilling and advanced extraction technology.